Cardiac Biotech Solutions 

$0.03
4
+$0+0% Friday 20:00

Statistics

Day High
0.03
Day Low
0.03
52W High
0.08
52W Low
0.02
Volume
10,090
Avg. Volume
17,518
Mkt Cap
4.96M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q2 2016
Q3 2016
Q1 2017
Q2 2017
Q4 2017
Q1 2018
Q2 2018
-0.01
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0019

Financials

-4,100%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
82,000Revenue
-3.36MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CBSC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories is a competitor because it also operates in the medical devices and healthcare sector, offering diagnostic products and services similar to CB Scientific.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc engages in the development, manufacturing, and marketing of device-based medical therapies, which competes with CB Scientific's offerings in the medical device space.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. provides a portfolio of healthcare products, including renal and hospital products, which competes with CB Scientific's medical diagnostic and research tools.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing with CB Scientific in the medical devices market.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation is involved in the development, manufacturing, and marketing of medical devices, which directly competes with CB Scientific's product offerings.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. designs, manufactures, and markets orthopedic reconstructive products; competing with CB Scientific in the broader medical devices sector.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, competing with CB Scientific in the medical devices and diagnostics market.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products which compete with CB Scientific's diagnostics and research tools.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation operates in the medical, professional, industrial, and commercial sectors, offering products and services that compete with CB Scientific's diagnostics and research offerings.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with CB Scientific in the life sciences and diagnostics sectors.

About

Cardiac Biotech Solutions Inc., through its international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians. Cardiac Biotech Solutions' wholly owned U.S. subsidiary, My-Cardia (USA), Inc., develops ECG recording device worn by patients in an ambulatory setting for up to 30 days.
Show more...
CEO
Mr. Charles K. Martin III
Employees
5
Country
US
ISIN
US12506E1038

Listings

0 Comments

Share your thoughts

FAQ

What is Cardiac Biotech Solutions stock price today?
The current price of CBSC is $0.03 USD — it has increased by +0% in the past 24 hours. Watch Cardiac Biotech Solutions stock price performance more closely on the chart.
What is Cardiac Biotech Solutions stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cardiac Biotech Solutions stocks are traded under the ticker CBSC.
What is Cardiac Biotech Solutions market cap?
Today Cardiac Biotech Solutions has the market capitalization of 4.96M
What were Cardiac Biotech Solutions earnings last quarter?
CBSC earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cardiac Biotech Solutions revenue for the last year?
Cardiac Biotech Solutions revenue for the last year amounts to 82,000 USD.
What is Cardiac Biotech Solutions net income for the last year?
CBSC net income for the last year is -3.36M USD.
How many employees does Cardiac Biotech Solutions have?
As of April 01, 2026, the company has 5 employees.
In which sector is Cardiac Biotech Solutions located?
Cardiac Biotech Solutions operates in the Health Care sector.
When did Cardiac Biotech Solutions complete a stock split?
The last stock split for Cardiac Biotech Solutions was on February 16, 2016 with a ratio of 1:75.
Where is Cardiac Biotech Solutions headquartered?
Cardiac Biotech Solutions is headquartered in Las Vegas, US.